• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重钙结石形成活性与骨重塑标志物的关联。

Association of severe calcium lithogenic activity and bone remodeling markers.

机构信息

Department of Urology, San Cecilio University Hospital, Granada, Spain.

出版信息

Urology. 2013 Jul;82(1):16-21. doi: 10.1016/j.urology.2013.02.035. Epub 2013 Apr 16.

DOI:10.1016/j.urology.2013.02.035
PMID:23601442
Abstract

OBJECTIVE

To establish cutoff points for markers of bone remodeling that allow for screening of patients at risk for serious lithogenic activity.

MATERIALS AND METHODS

We conducted a cross-sectional study with 182 patients (aged between 25 and 60 years) divided into 3 groups: group 1, 56 patients without lithiasis; group 2, 67 patients with light calcium lithiasis; and group 3, 59 patients with severe calcium lithiasis. The criteria for inclusion in and exclusion from the study were established, and light and severe lithogenic activity were defined. Metabolic variables in blood and urine, along with bone densitometry, were studied for the groups. Statistical analysis of the results and preparation of receiver operating characteristic curves to establish optimal cutoff points were performed.

RESULTS

The patients in group 3 showed the greatest bone mineral density loss and the highest values for markers of bone remodeling, together with increased 24-hour calciuria. Using the receiver operating characteristic curves developed and based on statistical significance (P = .0001), the following cutoff points for severe lithogenic activity, with a sensitivity between 75% and 85%, were established: β-crosslaps >0.331 ng/mL; osteocalcin >13.2 ng/mL; β-crosslaps/osteocalcin >0.024; 24-hour calciuria >306.6 mg; and fasting urine calcium/creatinine >0.105.

CONCLUSION

Patients with calcium lithiasis and elevated values for osteocalcin, β-crosslaps, β-crosslaps/osteocalcin, 24-hour calciuria, and fasting urine calcium/creatinine may present a high risk of severe lithogenic activity.

摘要

目的

确定用于筛选有严重成石活性风险患者的骨重塑标志物截断值。

材料与方法

我们进行了一项横断面研究,共纳入 182 例(年龄 25-60 岁)患者,分为 3 组:组 1,56 例无结石患者;组 2,67 例轻度钙结石患者;组 3,59 例严重钙结石患者。确定了纳入和排除标准,并定义了轻度和重度成石活性。对各组的血液和尿液代谢变量以及骨密度进行了研究。对结果进行了统计分析,并绘制了受试者工作特征曲线以确定最佳截断值。

结果

组 3 患者的骨矿物质密度损失最大,骨重塑标志物水平最高,24 小时尿钙排泄量增加。使用所建立的和基于统计学意义(P =.0001)的受试者工作特征曲线,确定了以下用于重度成石活性的截断值(敏感性在 75%-85%之间):β-crosslaps >0.331 ng/mL;骨钙素>13.2 ng/mL;β-crosslaps/骨钙素>0.024;24 小时尿钙>306.6 mg;空腹尿钙/肌酐>0.105。

结论

钙结石患者和骨钙素、β-crosslaps、β-crosslaps/骨钙素、24 小时尿钙排泄量、空腹尿钙/肌酐水平升高的患者可能有严重成石活性的高风险。

相似文献

1
Association of severe calcium lithogenic activity and bone remodeling markers.严重钙结石形成活性与骨重塑标志物的关联。
Urology. 2013 Jul;82(1):16-21. doi: 10.1016/j.urology.2013.02.035. Epub 2013 Apr 16.
2
Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.骨质疏松症和骨质减少患者血清及尿液结石形成风险因素的回顾性研究。
Urology. 2015 Apr;85(4):782-5. doi: 10.1016/j.urology.2015.01.019.
3
Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.特发性钙肾结石患者严重成石活性的生化决定因素。
Urology. 2012 Jan;79(1):48-54. doi: 10.1016/j.urology.2011.07.1382. Epub 2011 Sep 9.
4
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.枸橼酸盐和钙:枸橼酸盐比值在钙性肾结石和严重结石形成患者中的重要性。
BJU Int. 2013 Apr;111(4):622-7. doi: 10.1111/j.1464-410X.2012.11292.x. Epub 2012 Jul 3.
5
Mineral density and bone remodelling markers in patients with calcium lithiasis.钙结石患者的骨密度和骨重建标志物。
BJU Int. 2011 Dec;108(11):1903-8; discussion 1908. doi: 10.1111/j.1464-410X.2011.10167.x. Epub 2011 May 9.
6
Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.骨重塑标志物作为骨质减少-骨质疏松症患者的结石形成风险因素
Int Urol Nephrol. 2016 Nov;48(11):1777-1781. doi: 10.1007/s11255-016-1361-5. Epub 2016 Jul 4.
7
Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density.患有肾钙质结石、严重成石活性和骨密度丧失的患者的代谢-矿物质研究。
Singapore Med J. 2012 Dec;53(12):808-13.
8
The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.在骨质减少/骨质疏松患者中,尿钙作为致石因素的重要性。
Int Urol Nephrol. 2015 Mar;47(3):445-9. doi: 10.1007/s11255-015-0918-z. Epub 2015 Feb 5.
9
Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.氨基双膦酸盐和噻嗪类药物在伴有骨质减少/骨质疏松症、高钙尿症和复发性肾钙结石的患者中的作用。
Urology. 2013 Apr;81(4):731-7. doi: 10.1016/j.urology.2012.12.013. Epub 2013 Jan 30.
10
[Blood serum osteocalcin and beta-crosslaps concentrations in patients after renal transplantation].肾移植术后患者血清骨钙素和β-交联羧基末端肽浓度
Przegl Lek. 2007;64(6):431-4.

引用本文的文献

1
Vitamin D metabolism in dogs with and without hypercalciuric calcium oxalate urolithiasis.患有和未患有高钙尿草酸钙尿路结石的犬类的维生素D代谢
J Vet Intern Med. 2019 Mar;33(2):758-763. doi: 10.1111/jvim.15442. Epub 2019 Mar 9.
2
Does idiopathic hypercalciuria affect bone metabolism during childhood? A prospective case-control study.特发性高钙尿症是否会影响儿童时期的骨代谢?一项前瞻性病例对照研究。
Pediatr Nephrol. 2018 Dec;33(12):2321-2328. doi: 10.1007/s00467-018-4027-y. Epub 2018 Jul 25.
3
Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.
骨重塑标志物作为骨质减少-骨质疏松症患者的结石形成风险因素
Int Urol Nephrol. 2016 Nov;48(11):1777-1781. doi: 10.1007/s11255-016-1361-5. Epub 2016 Jul 4.
4
The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.在骨质减少/骨质疏松患者中,尿钙作为致石因素的重要性。
Int Urol Nephrol. 2015 Mar;47(3):445-9. doi: 10.1007/s11255-015-0918-z. Epub 2015 Feb 5.
5
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison.钙肾结石、动脉僵硬度与骨密度之间的关系:揭示结石-骨骼-血管联系。
J Nephrol. 2015 Oct;28(5):549-55. doi: 10.1007/s40620-014-0146-0. Epub 2014 Sep 30.